Meichen Yin
Hangzhou, 310006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Immune infiltration related circular RNA, circGLIS2, facilitated progression of endometriosis through miR-4731-5p/IL-1β axis.
Journal: International journal of biological macromolecules
Published: August 03, 2024
Investigation of the Therapeutic Effect of Salbutamol on Endometriosis in a Mouse Model.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: July 30, 2023
A method for isolating and culturing ectopic epithelial and stromal cells to study human adenomyosis.
Journal: Archives of gynecology and obstetrics
Published: July 26, 2023
Long non coding RNA, C8orf49, a novel diagnostic and prognostic biomarker, enhances PTEN/FZD4-mediated cell growth and metastasis by sponging miR-1323 in endometriosis.
Journal: Molecular and cellular endocrinology
Published: June 22, 2023
ROMA Index Is an Effective Predictor for Advanced Endometrial Cancer before Surgery.
Journal: Disease markers
Published: November 24, 2022
A chimeric switch-receptor PD1-DAP10-41BB augments NK92-cell activation and killing for human lung Cancer H1299 Cell.
Journal: Biochemical and biophysical research communications
Published: December 28, 2021
Comprehensive Analysis of RNA-Seq in Endometriosis Reveals Competing Endogenous RNA Network Composed of circRNA, lncRNA and mRNA.
Journal: Frontiers in genetics
Published: December 03, 2021
Chimeric antigen receptor-modified macrophages trigger systemic anti-tumour immunity.
Journal: The Journal of pathology
Published: May 14, 2020
A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell.
Journal: Biochemical and biophysical research communications
Published: December 02, 2019
Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Journal: Journal of ovarian research
Published: August 06, 2019
KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors.
Journal: OncoTargets and therapy
Published: July 15, 2019
Last Updated: 09/26/2026